Chemical Compound Review:
TERTATOLOL 1-(tert-butylamino)-3- thiochroman-8-yloxy...
Synonyms:
Tertatololum, dl-Tertatalol, dl-Tertatolol, rac Tertatolol, SureCN49634, ...
- Tertatolol-induced lupus. Roudier, J., Delmas, P.D. Arthritis Rheum. (1988)
- Intracardiac electrophysiological study of S-2395 in intact and chemically sympathectomized dogs. Guimond, C., Vasseur, C., Godin, D., LeBlanc, A.R., Nadeau, R. Eur. Heart J. (1983)
- Acute central and renal haemodynamic responses to tertatolol and propranolol in patients with arterial hypertension following head injury. Leeman, M., Naeije, R., Degaute, J.P., Brackman, F., Prost, J.F. J. Hypertens. (1986)
- Hemodynamic and pharmacokinetic study of tertatolol in patients with alcoholic cirrhosis and portal hypertension. Calès, P., Caillau, H., Crambes, O., Vinel, J.P., Desmorat, H., Rocher, I., Jung, L., Urien, S., Brouard, R., Pascal, J.P. J. Hepatol. (1993)
- 5-HT1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Andrews, N., Hogg, S., Gonzalez, L.E., File, S.E. Eur. J. Pharmacol. (1994)
- Certain beta-blockers can decrease beta-adrenergic receptor number: I. Acute reduction in receptor number by tertatolol and bopindolol. De Blasi, A., Fratelli, M., Marasco, O. Circ. Res. (1988)
- Comparative study of pre- and postsynaptic 5-HT1A receptor modulation of anxiety in two ethological animal tests. File, S.E., Gonzalez, L.E., Andrews, N. J. Neurosci. (1996)
- Reduction of beta-adrenergic receptors by tertatolol: an additional mechanism for beta-adrenergic blockade. De Blasi, A., Lipartiti, M., Pirone, F., Rochat, C., Prost, J.F., Garattini, S. Clin. Pharmacol. Ther. (1986)
- Acute effects of tertatolol and nadolol on systemic and renal hemodynamics in patients with essential hypertension. Degaute, J.P., Naeije, R., Abramowicz, M., Leeman, M., Schoutens, A., Prost, J.F. Am. J. Hypertens. (1988)
- Central sites and mechanisms of the hypotensive and bradycardic effects of the narcotic analgesic agent fentanyl. Laubie, M., Schmitt, H., Drouillat, M. Naunyn Schmiedebergs Arch. Pharmacol. (1977)
- Action of clonidine on the baroreceptor pathway and medullary sites mediating vagal bradycardia. Laubie, M., Schmitt, H., Drouillat, M. Eur. J. Pharmacol. (1976)
- Nicardipine decreases blood pressure and heart rate at nucleus tractus solitarii of spontaneously hypertensive rats. Champéroux, P., Brisac, A.M., Laurent, S., Schmitt, H. J. Cardiovasc. Pharmacol. (1989)
- Comparative renal and cardiac effects of tertatolol and enalapril in essential hypertension. Ribstein, J., Du Cailar, G., Brouard, R., Mimran, A. Cardiology (1993)
- The beta adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney. Verbeuren, T.J., Zonnekeyn, L.L., Prost, J.F., Rochat, C., Thomas, J.R., Herman, A.G. J. Pharmacol. Exp. Ther. (1988)
- Effects of tertatolol on post- and prejunctional beta adrenoceptors. Verbeuren, T.J., Laekeman, G., Majchrowicz, B.B., Jordaens, F.H., Zonnekeyn, L.L., Herman, A.G. J. Pharmacol. Exp. Ther. (1985)
- Effects of chronic beta-blocker treatment on catecholamine levels in spontaneously hypertensive rats. Heimburger, M., Denoroy, L., Renaud, B., Sassard, J., Cohen, Y., Wepierre, J. Biochem. Pharmacol. (1983)
- Tertatolol, a new beta-blocker, is a serotonin (5-hydroxytryptamine1A) receptor antagonist in rat brain. Prisco, S., Cagnotto, A., Talone, D., De Blasi, A., Mennini, T., Esposito, E. J. Pharmacol. Exp. Ther. (1993)
- Discriminative stimulus effects of 8-hydroxy-2-(di-n-propylamino)tetralin in pigeons and rats: species similarities and differences. Kleven, M.S., Koek, W. J. Pharmacol. Exp. Ther. (1998)
- Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans. Moro, C., Crampes, F., Sengenes, C., De Glisezinski, I., Galitzky, J., Thalamas, C., Lafontan, M., Berlan, M. FASEB J. (2004)
- Up-regulation of a thermogenesis-related gene (UCP1) and down-regulation of PPARgamma and aP2 genes in adipose tissue: possible features of the antiobesity effects of a beta3-adrenergic agonist. Margareto, J., Larrarte, E., Marti, A., Martinez, J.A. Biochem. Pharmacol. (2001)
- Preserved renal perfusion during beta blockade by tertatolol with and without cyclooxygenase inhibition in normal humans. Reuse, C., Leeman, M., Degaute, J.P., Abramowicz, M., Prost, J.F., Naeije, R. Journal of clinical pharmacology. (1988)
- Chronic effects of tertatolol on renal function in hypertensive patients with mild chronic renal failure. Hannedouche, T., Brouard, R., Godin, M., Kleinknecht, D., Paillard, F., Grünfeld, J.P. Nephrol. Dial. Transplant. (1991)
- Tertatolol increases glomerular filtration and urinary sodium in anesthetized rats. Plante, G.E., Prévost, C., Sirois, P., Rochat, C., Prost, J.F. J. Pharmacol. Exp. Ther. (1989)
- The Tertatolol International Multicenter Study (T.I.M.S.). Predicting factors of an efficient therapy. Agnes, E., Vandermercken, C., Prost, J.F., Safar, M.E. Am. J. Hypertens. (1989)
- Selective infusion of tertatolol into the renal artery induces a local vasodilator effect in humans. Demonstration by the continuous thermodilution method. Nitenberg, A., Prost, J.F., Joussen, J.M., Blanchet, F., Dutray-Dupagne, C. Am. J. Hypertens. (1989)
- Determination of tertatolol enantiomers in biological fluids by high-performance liquid chromatography. Lave, T., Efthymiopoulos, C., Koffel, J.C., Jung, L. J. Chromatogr. (1991)